ENSG Stock Analysis: Buy, Sell, or Hold?
ENSG - The Ensign Group, Inc.
$172.56
0.90 (0.52%)
▲
5d:
-3.14%
30d:
-0.94%
90d:
-4.3%
BUY
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 04, 2026
TODAY
Get Alerted When ENSG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ENSG shows positive signals but monitor for confirmation. Market pricing in 0.9% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ENSG shows positive signals but monitor for confirmation. Market pricing in 0.9% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$257.23
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$159.72
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ENSG is currently trading at $172.56, which is considered oversold relative to its 30-day fair value range of $173.00 to $179.04. The stock's valuation (Forward PE: 23.7) is in line with its historical norms (24.4). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This pessimistic expectation contrasts with the company's recent 6.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ENSG is showing sideways momentum. The price is currently testing key support at $167.43. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ENSG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $208.20 (+20.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ENSG is showing sideways momentum. The price is currently testing key support at $167.43. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ENSG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $208.20 (+20.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$173.00 -
$179.04
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.7% below Wall St target ($208.20)
Fair Price Analysis
30-Day Fair Range
$173.00 -
$179.04
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$5.34
(3.1%)
Support & Resistance Levels
Support Level
$167.43
Resistance Level
$182.00
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
23.74
Wall Street Target
$208.20
(+20.7%)
Revenue Growth (YoY)
19.8%
Earnings Growth (YoY)
6.0%
Profit Margin
6.8%
Valuation Discount vs History
-0.9% cheaper
PE vs Historical
23.7 vs 24.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.9%
(market-implied from PE analysis)
1-Year Target
$171.01
(-1%)
2-Year Target
$169.47
(-2%)
3-Year Target
$167.94
(-3%)
3-Yr Target (if PE normalizes)
(PE: 24→24)
$172.63
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.7, Growth: 11.5%)
$239.07
(+39%)
Base:
(SPY PE: 22.3, Growth: 11.5%)
$224.60
(+30%)
Bear:
(PE: 19.0, Growth: 11.5%)
$190.91
(+11%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 30.38 | Current EPS (TTM): $5.65
Bull Case
$242.95
(+41%)
Analyst growth 28.7%, PE expands to 33.4
Base Case
$220.87
(+28%)
Market implied 28.7%, PE stable at 30.4
Bear Case
$116.73
(-32%)
Severe decline -20.0%, PE contracts to 25.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.7 to 24.4
Stabilization Target:
$177.38
(+2.8%)
PE Expansion Potential:
+2.8%
Last updated: February 03, 2026 4:14 AM ET
Data refreshes hourly during market hours. Next update: 5:14 AM
Data refreshes hourly during market hours. Next update: 5:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENSG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Barry M Smith
SELL
700 shares
2025-09-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$529 | 62 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$238 | 54 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$140 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$17 | 50 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$28 | 61 BUY |
